Abstract
We have assessed the growth response of Chinese-hamster ovary (CHO) cells to activation of recombinantly expressed G-protein-coupled muscarinic M(2) or M(3) acetylcholine receptors (AChRs). We show that activation of these receptors leads to divergent growth responses: M(2) AChR activation causes an increase in DNA synthesis, whereas M(3) AChR activation causes a dramatic decrease in DNA synthesis. We have characterized the M(3) AChR-mediated growth inhibition and show that it involves a G(1) phase cell-cycle arrest. Further analysis of this arrest indicates that it involves an increase in expression of the cyclin-dependent kinase (CDK) inhibitor, p21(Cip1/Waf1) (where Cip1 is CDK-interacting protein 1 and Waf1 is wild-type p53-associated fragment 1), in response to M(3) AChR activation. This increase in protein expression leads to an increase in p21(Cip1/Waf1) association with CDK2, a decrease in CDK2 activity and an accumulation of hypophosphorylated retinoblastoma protein. The increased p21(Cip1/Waf1) expression is due, at least in part, to an increase in p21(Cip1/Waf1) mRNA, and receptor-mediated changes in phosphorylation of c-Jun provide a mechanism to account for this p21(Cip1/Waf1) transcriptional regulation. Evaluation of the extracellular signal-regulated protein kinase and c-Jun N-terminal kinase activities has shown striking differences in the profiles of activation of these mitogen-activated protein kinases by the M(2) and M(3) AChRs, and their potential involvement in mediating growth arrest by the M(3) AChR is discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 549-59 |
| Number of pages | 11 |
| Journal | Biochemical Journal |
| Volume | 367 |
| Issue number | Pt 2 |
| Early online date | 18 Jul 2002 |
| DOIs | |
| Publication status | Published - 15 Oct 2002 |
| Externally published | Yes |
Keywords
- Animals
- CDC2-CDC28 Kinases
- CHO Cells
- Carbachol/pharmacology
- Cell Division/drug effects
- Cholinergic Agonists/pharmacology
- Cricetinae
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinases/metabolism
- Cyclins/genetics
- DNA/biosynthesis
- G1 Phase/drug effects
- Humans
- JNK Mitogen-Activated Protein Kinases
- Mitogen-Activated Protein Kinases/drug effects
- Phosphorylation
- Protein Serine-Threonine Kinases/metabolism
- Receptor, Muscarinic M2
- Receptor, Muscarinic M3
- Receptors, Muscarinic/drug effects
- Recombinant Proteins/genetics
- Retinoblastoma Protein/metabolism